Literature DB >> 19241011

Profiling the tyrosine phosphorylation state using SH2 domains.

Kevin Dierck1, Kazuya Machida, Bruce J Mayer, Peter Nollau.   

Abstract

Global monitoring of cellular signaling activity is of great importance for the understanding of the regulation of complex signaling networks and the characterization of signaling pathways deregulated in diseases. Tyrosine phosphorylation of intracellular signaling proteins followed by the recognition and binding of Src homology 2 (SH2) domains are key mechanisms in the downstream transmission of many important biological signals. SH2 domains, comprising 120 members in humans, are small modular protein binding domains that recognize tyrosine phosphorylated signaling proteins with high specificity. Based on these binding properties, the large number of naturally occurring and currently available SH2 domains serve as excellent probes for the comprehensive profiling of the cellular state of signaling activity. Here we have described different experimental strategies for global SH2 profiling: high-resolution phosphoproteomic scanning by far-Western Blot analysis and high-throughput profiling by our recently developed oligonucleotide-tagged multiplex assay (OTM) and Rosette assay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241011     DOI: 10.1007/978-1-60327-834-8_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors:  Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Purification, crystallization and preliminary X-ray diffraction analysis of the Fyn SH2 domain and its complex with a phosphotyrosine peptide.

Authors:  Radu Huculeci; Lieven Buts; Tom Lenaerts; Nico A J van Nuland; Abel Garcia-Pino
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-29

3.  Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation.

Authors:  Laura C Kelley; Amanda Gatesman Ammer; Karen E Hayes; Karen H Martin; Kazuya Machida; Lin Jia; Bruce J Mayer; Scott A Weed
Journal:  J Cell Sci       Date:  2010-10-27       Impact factor: 5.285

4.  Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues.

Authors:  Peter Nollau; Gerrit Wolters-Eisfeld; Naghmeh Mortezai; Anna-Katharina Kurze; Birgit Klampe; Annegret Debus; Maximilian Bockhorn; Axel Niendorf; Christoph Wagener
Journal:  J Histochem Cytochem       Date:  2012-12-28       Impact factor: 2.479

5.  Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling.

Authors:  Kazuya Machida; Malik Khenkhar; Peter Nollau
Journal:  Genes Cancer       Date:  2012-05

6.  Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling.

Authors:  Kazuya Machida; Steven Eschrich; Jiannong Li; Yun Bai; John Koomen; Bruce J Mayer; Eric B Haura
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

7.  Splice-mediated motif switching regulates disabled-1 phosphorylation and SH2 domain interactions.

Authors:  Zhihua Gao; Ho Yin Poon; Lei Li; Xiaodong Li; Elena Palmesino; Darryl D Glubrecht; Karen Colwill; Indrani Dutta; Artur Kania; Tony Pawson; Roseline Godbout
Journal:  Mol Cell Biol       Date:  2012-05-14       Impact factor: 4.272

8.  Phosphotyrosine recognition domains: the typical, the atypical and the versatile.

Authors:  Tomonori Kaneko; Rakesh Joshi; Stephan M Feller; Shawn Sc Li
Journal:  Cell Commun Signal       Date:  2012-11-07       Impact factor: 5.712

9.  Functional interaction of SCAI with the SWI/SNF complex for transcription and tumor cell invasion.

Authors:  Camilla Kreßner; Peter Nollau; Robert Grosse; Dominique T Brandt
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

10.  LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.

Authors:  Jochen J Frietsch; Carolin Kastner; Thomas G P Grunewald; Hardy Schweigel; Peter Nollau; Janine Ziermann; Joachim H Clement; Paul La Rosée; Andreas Hochhaus; Elke Butt
Journal:  Oncotarget       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.